
A 45-year-old female patient was referred for peptide receptor radionuclide therapy of liver metastases of neuroendocrine origin; the patient had undergone 2 years earlier surgical resection of a grade 2 neuroendocrine neoplasm of ampulla of Vater infiltrating the duodenal submucosa and muscular layers and the neighboring pancreatic tissue. Post-therapy whole-body scan performed to evaluate in vivo radiopharmaceutical distribution confirmed high accumulation in liver lesions and revealed increased uptake in the hip bone. Bone scan and corresponding CT images demonstrated changes of Paget disease in the same district.
Organometallic Compounds, Humans, peptide receptor radionuclide therapy, false positive result, 177Lu-DOTATATE, Paget disease, Female, Whole Body Imaging, Receptors, Somatostatin, Octreotide, Osteitis Deformans, Radionuclide Imaging, Tomography, X-Ray Computed, Bone and Bones
Organometallic Compounds, Humans, peptide receptor radionuclide therapy, false positive result, 177Lu-DOTATATE, Paget disease, Female, Whole Body Imaging, Receptors, Somatostatin, Octreotide, Osteitis Deformans, Radionuclide Imaging, Tomography, X-Ray Computed, Bone and Bones
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 3 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
